Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.
about
Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actionsProtein crosslinking by transglutaminase controls cuticle morphogenesis in DrosophilaRole of calcium in the conformational dynamics of factor XIII activation examined by hydrogen-deuterium exchange coupled with MALDI-TOF MS.Factor XIII activity mediates red blood cell retention in venous thrombi.Functional production and characterization of a fibrin-specific single-chain antibody fragment from Bacillus subtilis: effects of molecular chaperones and a wall-bound protease on antibody fragment production.α-α Cross-links increase fibrin fiber elasticity and stiffnessAntiadhesive effect of fibrinogen: a safeguard for thrombus stabilityFactor XIII Transglutaminase Supports the Resolution of Mucosal Damage in Experimental Colitis.Critical role of factor XIII in the initial stages of carbon tetrachloride-induced adult liver remodeling.Transglutaminase-mediated remodeling of the human erythrocyte membrane skeleton: relevance for erythrocyte diseases with shortened cell lifespan.Fibronectin is essential for survival but is dispensable for proliferation of hepatocytes in acute liver injury in mice.Discordant fibrin formation in hemophilia.A comparison of the mechanical and structural properties of fibrin fibers with other protein fibers.Characteristics of fibrin formation and clot stability in individuals with congenital type IIb protein C deficiencyThrombelastography and tromboelastometry in assessing coagulopathy in trauma.Current management of massive hemorrhage in trauma.Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for binding to the gamma'-chain.Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase.The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking.Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot.Coagulopathy and traumatic shock: characterizing hemostatic function during the critical period prior to fluid resuscitation.Sepsis-associated disseminated intravascular coagulation and thromboembolic disease.HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function.Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins.Fibrinogen Hershey IV: a novel dysfibrinogen with a gammaV411I mutation in the integrin alpha(IIb)beta(3) binding site
P2860
Q28211940-4558137D-FBAC-4479-AEF4-0F1FF4FF9356Q33728291-69352E64-914D-407B-AA06-5EFF4AD6DBDFQ33922523-080E70D0-3DDC-44B8-AE26-E7BE40434151Q33944224-A25E650E-3EC6-4D49-8548-29E9A811124CQ34101697-313635D5-CDD4-40FA-9564-87D76A9BB45DQ34120791-F051F5C9-65DC-4128-894D-E6D016ABC6CFQ35628915-40F6F60F-B8AA-4C20-B4E9-C12AC2D63FE1Q35670403-2CE80ABE-ED02-424C-B045-623EE5F65E48Q35679409-9D807C75-1ECB-42B2-B46F-B03D302E390CQ35856363-AAEED7A2-9FA0-475C-A050-0EF444A13CE8Q35968935-817A07D6-AFFC-43DB-9C28-F72623E31823Q36105820-11EB4605-4D04-4B28-95F4-8873E9C2BB7DQ36977727-096CA623-F421-4C92-B433-BCF76875DED5Q37059445-A24615A8-DE9A-47B8-8230-843357988F70Q37379818-9FE53791-5DFB-449B-B06D-9F7D7E7D732EQ38024924-82AEDD32-5D7C-497F-99AB-56CF3A95F080Q38263866-FE80FFCE-E536-4862-9108-E7537CEE9D61Q39198610-4BEFC107-B0CE-4D2C-8303-AC8CC12C1F08Q40431605-7F9EAFA8-B717-4E99-B6AB-709C955C8FE3Q41825512-3F6D4EE7-E1C4-4EFE-9185-741F9DDB3312Q42124839-5C6FB391-FC7F-4D3A-A9D7-F592585CD416Q42588928-500DA0B1-ECCC-4F8A-B7F7-28A1B6B8A1B2Q42930003-1DC866F1-00A0-4B41-AA4D-E75F1204A8EFQ43120462-073272A6-830B-4D74-9D0E-60746A869F3BQ57116809-8A4CB993-2D62-487A-A0D2-FB0442817868
P2860
Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.
@ast
Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.
@en
Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.
@nl
type
label
Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.
@ast
Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.
@en
Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.
@nl
prefLabel
Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.
@ast
Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.
@en
Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.
@nl
P1476
Factor XIII: structure, activation, and interactions with fibrinogen and fibrin
@en
P2093
P304
P356
10.1111/J.1749-6632.2001.TB03516.X
P407
P577
2001-01-01T00:00:00Z